Myeloid cells in atherosclerosis: A delicate balance of anti-inflammatory and proinflammatory mechanisms

Current Opinion in Lipidology

Volumn 24, Issue 5, 2013, Pages 371-380

  Koltsova, Ekaterina K ^a   Hedrick, Catherine C ^a   Ley, Klaus ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHLORDANE; COLONY STIMULATING FACTOR 1; F4 80 ANTIGEN; GLYCOPROTEIN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LY6C PROTEIN; LYMPHOCYTE ANTIGEN; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TRIB1; TRANSCRIPTION FACTOR ZBTB46; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; FOAM CELL; GENE EXPRESSION; HEMATOPOIETIC SYSTEM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; M1 LIKE MACROPHAGE; M2 LIKE MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE POLARIZATION; MONOCYTE; MONOCYTE DENDRITIC CELL PRECURSOR CELL; NATURAL KILLER T CELL; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; POLARIZATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; TISSUE REPAIR;

ANIMALS; ATHEROSCLEROSIS; DENDRITIC CELLS; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOCYTES; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 84883809756     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328363d298     Document Type: Review

References (113)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252
2. Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 2012; 122:787-795
3. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11:723-737
4. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-899
5. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013; 339:161-166
6. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145:341-355
7. Koltsova EK, Ley K. How dendritic cells shape atherosclerosis. Trends Immunol 2011; 32:540-547
8. Bobryshev YV, Babaev VR, Lord RS, Watanabe T. Ultrastructural identification of cells with dendritic cell appearance in atherosclerotic aorta of apolipoprotein E deficient mice. J Submicrosc Cytol Pathol 1999; 31:527-531
9. Galkina E, Kadl A, Sanders J, et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006; 203:1273-1282
10. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012; 110:875-888
11. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001; 104:503-516
12. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arteriosclerosis, thrombosis, and vascular biology 2011; 31:1506-1516
13. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 2010; 7:77-86
14. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: Initiators and decision shapers. Semin Immunopathol 2009; 31:35-47
15. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat Rev Immunol 2008; 8:802-815
16. Randolph GJ. Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr Opin Lipidol 2008; 19:462-468
17. Gautier EL, Jakubzick C, Randolph GJ. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:1412-1418
18. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473:317-325
19. Williams HJ, Fisher EA, Greaves DR. Macrophage differentiation and function in atherosclerosis: Opportunities for therapeutic intervention? J innate Immun 2012; 4:498-508
20. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32:2045-2051
21. Choi JH, Cheong C, Dandamudi DB, et al. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 2011; 35:819-831
22. Subramanian M, Thorp E, Hansson GK, Tabas I. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in dendritic cells. J Clin Invest 2013; 123:179-188
23. Spann NJ, Garmire LX, McDonald JG, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012; 151:138-152
24. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol 2006; 18:49-53
25. Gautier EL, Shay T, Miller J, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 2012; 13:1118-1128
26. Merad M, Sathe P, Helft J, et al. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31:563-604
27. Wu H, Gower RM, Wang H, et al. Functional role of CD11c- monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009; 119:2708-2717
28. Koltsova EK, Garcia Z, Chodaczek G, et al. Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest 2012; 122: 3114-3126
29. Satpathy AT, Wu X, Albring JC, Murphy KM. Re(de)fining the dendritic cell lineage. Nat Immunol 2012; 13:1145-1154
30. Lewis KL, Reizis B. Dendritic cells: Arbiters of immunity and immunological tolerance. Cold Spring Harb Perspect Biol 2012; 4:a007401
31. Serbina NV, Salazar-Mather TP, Biron CA, et al. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003; 19:59-70
32. Dunay IR, Damatta RA, Fux B, et al. Gr1(-) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008; 29:306-317
33. Buono C, Pang H, Uchida Y, et al. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2004; 109:2009-2015
34. Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012; 336:86-90
35. Hashimoto D, Chow A, Noizar C, et al. Tissue-resident macrophages self maintain locally throught adult life with minimal contribution from circulating monocytes. Immunity 2013; 792-804
36. Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011; 17:1410-1422
37. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12:204-212
38. Fogg DK, Sibon C, Miled C, et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006; 311:83-87
39. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19:71-82
40. 3CR1 in their response to inflammation. J Exp Med 2009; 206:595-606
41. Carlin LM, Stamatiades EG, Auffray C, et al. Nr4a1-dependent Ly6Clow monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013; 153:362-375
42. Cros J, Cagnard N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33:375-386
43. Hanna RN, Shaked I, Hubbeling HG, et al. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 2012; 110:416-427
44. Hamers AA, Vos M, Rassam F, et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res 2012; 110:428-438
45. Gower RM, Wu H, Foster GA, et al. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 2011; 31:160-166
46. 3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117:185-194
47. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-Associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117:195-205
48. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27:669-692
49. Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327:656-661
50. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41:37S-42S
51. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1:297-329
52. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27:165-197
53. Stewart CR, Stuart LM, Wilkinson K, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11:155-161
54. Choi SH, Harkewicz R, Lee JH, et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009; 104:1355-1363
55. Miller YI, Choi SH, Wiesner P, et al. Oxidation-specific epitopes are dangerassociated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011; 108:235-248
56. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Current protocols in immunology/edited by John E. Coligan [et al.] Hoboken, NJ: John Wiley & Sons, 2008; Chapter 14:Unit 14 11
57. Vogt G, Nathan C. In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J Clin Investig 2011; 121:3889-3901
58. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: A question of balance. Arterioscler Thromb Vasc Biol 2009; 29:1419-1423
59. Branen L, Hovgaard L, Nitulescu M, et al. Inhibition of tumor necrosis factoralpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004; 24:2137-2142
60. Detmers PA, Hernandez M, Mudgett J, et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 2000; 165:3430-3435
61. Zhang X, Niessner A, Nakajima T, et al. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 2006; 98:524-531
62. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19:734-742
63. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003; 163:1117-1125
64. Hauer AD, Uyttenhove C, de Vos P, et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005; 112:1054-1062
65. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-To-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol 2006; 177:7303-7311
66. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13:453-461
67. Gleissner CA, Shaked I, Little KM, Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol 2010; 184:4810-4818
68. Kadl A, Meher AK, Sharma PR, et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 2010; 107:737-746
69. Feig JE, Vengrenyuk Y, Reiser V, et al. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS One 2012; 7:e39790
70. Egawa M, Mukai K, Yoshikawa S, et al. Inflammatory Monocytes Recruited to Allergic Skin Acquire an Anti-inflammatory M2 Phenotype via Basophil-Derived Interleukin-4. Immunity 2013; 38:570-580
71. Khallou-Laschet J, Varthaman A, Fornasa G, et al. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010; 5:e8852
72. Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229:176-185
73. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447:972-978
74. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009; 138:129-145
75. Wiesner P, Choi SH, Almazan F, et al. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010; 107:56-65
76. Mullick AE, Soldau K, Kiosses WB, et al. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 2008; 205:373-383
77. van Tits LJ, Stienstra R, van Lent PL, et al. Oxidized LDL enhances proinflammatory responses of alternatively activated M2 macrophages: A crucial role for Kruppel-like factor 2. Atherosclerosis 2011; 214:345-349
78. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17:179-188
79. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464:1357-1361
80. Grebe A, Latz E. Cholesterol crystals and inflammation. Curr Rheumatol Rep 2013; 15:313
81. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011; 12:231-238
82. Satoh T, Kidoya H, Naito H, et al. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 2013; 495:524-528
83. Satoh T, Takeuchi O, Vandenbon A, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11:936-944
84. El Chartouni C, Schwarzfischer L, Rehli M. Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology 2010; 215:821-825
85. Hanna RN, Carlin LM, Hubbeling HG, et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6Cmonocytes. Nat Immunol 2011; 12:778-785
86. 3CR1/apolipoprotein E double knockout mice. Circulation 2003; 107:1009-1016
87. 5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008; 117:1649-1657
88. 3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 2008; 28:243-250
89. 3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009; 113:963-972
90. Liu K, Victora GD, Schwickert TA, et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009; 324:392-397
91. Schmid MA, Kingston D, Boddupalli S, Manz MG. Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 2010; 234:32-44
92. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2:151-161
93. Hildner K, Edelson BT, Purtha WE, et al. Batf3 deficiency reveals a critical role for CD8alpha- dendritic cells in cytotoxic T cell immunity. Science 2008; 322:1097-1100
94. Cisse B, Caton ML, Lehner M, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008; 135:37-48
95. Schiavoni G, Mattei F, Sestili P, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(-) dendritic cells. J Exp Med 2002; 196:1415-1425
96. Hacker C, Kirsch RD, Ju XS, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4:380-386
97. Satpathy AT, Kc W, Albring JC, et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 2012; 209:1135-1152
98. Meredith MM, Liu K, Kamphorst AO, et al. Zinc finger transcription factor zdendritic cell is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 2012; 209:1583-1593
99. Meredith MM, Liu K, Darrasse-Jeze G, et al. Expression of the zinc finger transcription factor zdendritic cell (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 2012; 209:1153-1165
100. Paulson KE, Zhu SN, Chen M, et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 2010; 106:383-390
101. Daissormont IT, Christ A, Temmerman L, et al. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res 2011; 109:1387-1395
102. Macritchie N, Grassia G, Sabir SR, et al. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012; 32:2569-2579
103. Sun J, Hartvigsen K, Chou MY, et al. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 2010; 122:808-820
104. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775-1785
105. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103- dendritic cells induces Foxp3- regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-1764
106. Hashimoto D, Miller J, Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011; 35:323-335
107. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c- dendritic cells abrogates priming of CD8- T cells by exogenous cell-Associated antigens. Immunity 2002; 17:211-220
108. Gautier EL, Huby T, Saint-Charles F, et al. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009; 119:2367-2375
109. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6:399-409
110. Cho HJ, Shashkin P, Gleissner CA, et al. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genom 2007; 29:149-160
111. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010; 10:36-46
112. Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leuk Biol 2009; 86:1089-1095
113. Choudhury RP, Lee JM, Greaves DR. Mechanisms of disease: Macrophagederived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med 2005; 2:309-315